Gregory Palmateer

Gregory Palmateer

Auto-generated profile, based on publicly available information

Gregory Palmateer

Department of Urology, Emory University School of Medicine, Atlanta, GA, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2020 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
BDB.J. Daou
B.J. Daou
GPG. Palmateer
G. Palmateer
DWD.A. Wilkinson
D.A. Wilkinson
BTB.G. Thompson
B.G. Thompson
CMC.O. Maher
C.O. Maher
APA.S. Pandey
A.S. Pandey
BACKGROUND AND PURPOSE: T2 signal and FLAIR changes in patients undergoing stereotactic radiosurgery for brain AVMs may occur posttreatment and could result in adverse radiation effects. We aimed to evaluate outcomes in patients with these imaging changes, the frequency and degree of this response, and factors associated with it. MATERIALS AND METHODS: Through this retrospective cohort study, consecutive patients treated with stereotactic radiosurgery for brain AVMs who had at least 1 year of follow-up MR imaging were identified. Logistic regression analysis was used to evaluate predictors of outcomes. RESULTS: One-hundred-sixty AVMs were treated in 148 patients (mean, 35.6 years of age), including 42 (26.2%) pediatric AVMs. The mean MR imaging follow-up was 56.5 months. The median Spetzler-Martin grade was III. The mean maximal AVM diameter was 2.8 cm, and the mean AVM target volume was 7.4 mL. The median radiation dose was 16.5 Gy. New T2 signal and FLAIR hyperintensity were noted in 40% of AVMs. T2 FLAIR volumes at 3, 6, 12, 18, and 24 months were, respectively, 4.04, 55.47, 56.42, 48.06, and 29.38 mL Radiation-induced neurologic symptoms were encountered in 34.4%. In patients with radiation-induced imaging changes, 69.2% had new neurologic symptoms versus 9.5% of patients with no imaging changes (P = .0001). Imaging changes were significantly associated with new neurologic findings (P < .001). Larger AVM maximal diameter (P = .04) and the presence of multiple feeding arteries (P = .01) were associated with radiation-induced imaging changes. CONCLUSIONS: Radiation-induced imaging changes are common following linear particle accelerator–based stereotactic radiosurgery for brain AVMs, appear to peak at 12 months, and are significantly associated with new neurologic findings.

15 November 2024 in Urology Case Reports
Verified
Journal Article
Open access
ENEdouard H. Nicaise
Edouard H. Nicaise
EMErnest Morton
Ernest Morton
BCBenjamin Croll
Benjamin Croll
GPGregory Palmateer
Gregory Palmateer
GPGaurav Patel
Gaurav Patel
VMViraj Master
Viraj Master
Extra-adrenal, functional paraganglioma, if not medically controlled, requires early surgical resection. This can often be challenging when found in a retroperitoneal location, where resections are prone to lymphatic disruption and chyle leaks. Chylous ascites carry a significant risk of protein and caloric malnutrition, dehydration, and even mortality given the nutrient-rich characteristic of lost lymphatic fluid. Dietary modification involving minimal fat intake is often frontline conservative treatment, however, prolonged, heavy-volume chylous ascites will require advanced medical and surgical intervention. This case illustrates the difficulties, complexities, and solutions with multidisciplinary management of lymphatic leakage following resection of a functional, retroperitoneal paraganglioma.

25 October 2024 in Urology Case Reports
Verified
Journal Article
Open access
GPGregory Palmateer
Gregory Palmateer
ENEdouard H. Nicaise
Edouard H. Nicaise
JGJatin Gandhi
Jatin Gandhi
TGTaylor Goodstein
Taylor Goodstein
MSMichelle Sheng
Michelle Sheng
VMViraj Master
Viraj Master
Extramammary Paget disease (EMPD) is a rare dermatologic malignancy with a high rate of recurrence and increased risk for developing secondary malignancies. We present a 74-year-old male with previously resected primary EMPD who presented with widespread PSMA-avid lesions without prostatic uptake, an elevated PSA >100, and a negative prostate biopsy. Based on this and immunohistological staining, recurrent EMPD was suspected. However, after additional staining and reexamining their clinical presentation, metastatic prostate cancer without a detected primary lesion is more probable. This case highlights the diagnostic challenge variable expression of shared biomarkers found in EMPD and prostate cancer present to clinicians.